![Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response | Cell Death & Disease Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response | Cell Death & Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41419-019-1871-z/MediaObjects/41419_2019_1871_Fig1_HTML.png)
Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response | Cell Death & Disease
![The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference Berlin, Germany—February 20–23, 2019 | Diabetes Technology & Therapeutics The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference Berlin, Germany—February 20–23, 2019 | Diabetes Technology & Therapeutics](https://www.liebertpub.com/cms/10.1089/dia.2019.2525.abstracts/asset/images/medium/inline1.gif)
The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference Berlin, Germany—February 20–23, 2019 | Diabetes Technology & Therapeutics
![JPM | Free Full-Text | Documenting Pharmacogenomic Test Results in Electronic Health Records: Practical Considerations for Primary Care Teams JPM | Free Full-Text | Documenting Pharmacogenomic Test Results in Electronic Health Records: Practical Considerations for Primary Care Teams](https://www.mdpi.com/jpm/jpm-11-01296/article_deploy/html/images/jpm-11-01296-g001.png)